Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Gallium 68 PNT 6555

Next Previous
Drug Profile

Gallium 68 PNT 6555

Alternative Names: [Ga-68]-PNT-6555; Gallium-68-PNT-6555

Latest Information Update: 09 Jul 2025

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Tufts University School of Medicine
  • Developer POINT Biopharma
  • Class Diagnostic agents; Imaging agents; Radiopharmaceutical diagnostics; Radiopharmaceuticals
  • Mechanism of Action Positron-emission tomography enhancers; Radionuclide imaging enhancers
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase I Solid tumours

Most Recent Events

  • 25 Jun 2025 POINT Biopharma terminates the phase I FRONTIER clinical trials in Solid tumours (Late-stage disease, Metastatic disease) in USA and Canada (IV) due to business decision (NCT05432193)
  • 27 Dec 2023 POINT Biopharma has been acquired by Eli Lilly and Company
  • 29 Nov 2022 Pharmacodynamics data from a preclinical trial in Solid tumours released by POINT Biopharma

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top